Rabies Vaccines (Rabies Vaccine)

Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.

Also Known As:

Networked: 563 relevant articles (32 outcomes, 57 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Rupprecht, Charles E: 22 articles (05/2014 - 01/2003)
2.	Wilde, Henry: 9 articles (01/2011 - 02/2002)
3.	Madhusudana, S N: 8 articles (01/2015 - 07/2001)
4.	Mahendra, B J: 6 articles (01/2015 - 05/2004)
5.	Fooks, Anthony R: 6 articles (07/2014 - 04/2006)
6.	Slate, Dennis: 6 articles (09/2013 - 11/2009)
7.	Cohen, Joe: 6 articles (09/2011 - 01/2006)
8.	Malerczyk, Claudius: 6 articles (04/2009 - 02/2005)
9.	Franka, Richard: 5 articles (01/2014 - 11/2009)
10.	Centers for Disease Control and Prevention (CDC): 5 articles (04/2013 - 04/2007)

Related Diseases

1.	Rabies (Hydrophobia) 01/01/2010 - "The worldwide incidence of rabies and the inability of currently used vaccination strategies to provide highly potent and cost-effective therapy indicate the need for an improved rabies vaccine. " 01/01/1997 - "The breakthrough in production of highly efficacious human and animal rabies vaccines has led to successful rabies control in developed countries, but rabies is still a major health problem in many developing countries. " 03/01/1995 - "We evaluated the efficacy of purified duck embryo rabies vaccine (Lyssavac-N) under the above regimen conditions; although purified duck embryo rabies vaccine is highly immunogenic when given intramuscularly, it differs significantly from the other rabies vaccination products in that it is not a solution, but rather, a suspension with an added preservative. " 01/01/2009 - "The rabies leaflets were very effective in informing the people on how to deal with rabid animals, the earliest schedule for anti-rabies vaccine (ARV), and repeat vaccination. " 01/01/2007 - "Aerial delivery of oral rabies vaccine (ORV) baits has proven effective in large-scale efforts to immunize wildlife against rabies, and in North America this strategy currently is being used to immunize foxes (Urocyon cinereoargenteus and Vulpes vulpes), raccoons (Procyon lotor), and coyotes (Canis latrans). "
2.	Infection 01/01/1984 - "Immunization of mice with a rabies vaccine (antigenic value, 10 international units) at a concentration 30-fold high than that necessary for complete protection against homologous challenge with rabies virus was not protective against Mokola infection. " 11/01/2013 - "The results demonstrated that a single dose of rabies vaccine did not induce adequate protection against IRKV infection. " 11/01/1999 - "The pre-exposure regimen of inactivated rabies vaccine (Pasteur Mérieux) provides protection against infection. " 06/01/2015 - "Post exposure vaccination was performed at days 1, 2, 3, 4, 5 and 6 post infection (p.i.) with either SRV9 or inactivated rabies vaccine. " 02/01/2015 - "However, as rabies vaccines are outstandingly effective, no one should die of dog-transmitted infection. "
3.	Bites and Stings (Sting) 07/01/1998 - "To study the efficacy of post-exposure use of concentrated rabies vaccine prepared by primary hamster kidney cells during the past 16 years (1980-1995) in the Guangxi Zhuang Autonomous Region and the role of ambulant care for the victims injured by dog-bite. " 01/01/2015 - "Hence, the present study was undertaken to assess the safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. " 10/01/2010 - "This study was conducted to retrospectively evaluate a total of 4390 cases (1712 female, mean age: 25 years old; 2678 male, mean age: 35 years old) admitted to the rabies vaccine center of Giresun State Hospital, a province located at eastern Black-Sea region of Turkey, with the history of animal bite between the years of 2005-2009. " 12/01/1984 - "This study involved controlled treatment of dog-bite victims with suckling mouse brain (SMBV) or fetal bovine kidney (FBKV) rabies vaccines in an effort to determine which type to recommend for production and use in Nigeria. " 11/01/2015 - "These days immunization using the rabies vaccine has become standard practice for individuals who have suffered bites or scratches from an animal, or who have been exposed to the body fluids of an infected animal. "
4.	Wounds and Injuries (Trauma) 09/01/2008 - "Most injuries were associated with indigenous dogs; rabies vaccine was overprescribed. " 08/01/2005 - "We conducted a passive surveillance study in Uganda based in a random sample of health centres supplied with rabies vaccine to determine the characteristics of bite injury patients and establish the age and sex profiles of patients, the site of bites and their severity, wound management techniques and details of the vaccination course given. " 01/01/2003 - "This paper looks at several early cases in which children participated, including the first trial of cowpox vaccine, the first human trial of rabies vaccine, and the first treatment of Listerian wound antisepsis. " 08/01/2015 - "Currently, prompt wound cleansing after exposing to a potentially rabid animal and vaccination using rabies vaccine combined with administration of rabies immune globulin are the only effective methods for post-exposure prophylaxis against rabies. " 10/01/2014 - "Only two (9·5%) had their wounds treated and received an anti-rabies vaccine (ARV) after the bite incident. "
5.	Malaria 12/11/2008 - "Overall, there were 38 episodes of clinical malaria among recipients of RTS,S/AS01E, as compared with 86 episodes among recipients of the rabies vaccine, with an adjusted rate of efficacy against all malarial episodes of 56% (95% CI, 31 to 72; P<0.001). " 09/15/2011 - "In a double-blind, randomized trial, we immunized 400 Malian children with either the malaria vaccine or a control (rabies) vaccine and followed them for 6 months. " 12/11/2008 - "Among the 809 children who completed the study procedures according to the protocol, the cumulative number in whom clinical malaria developed was 32 of 402 assigned to receive RTS,S/AS01E and 66 of 407 assigned to receive the rabies vaccine; the adjusted efficacy rate for RTS,S/AS01E was 53% (95% confidence interval [CI], 28 to 69; P<0.001) on the basis of Cox regression. " 02/01/2011 - "At 15 months follow-up, 58 of 209 children in the RTS,S/AS01E group and 85 of 206 in the rabies vaccine group had first or only clinical malaria episode, vaccine efficacy 45·8% (24·1-61·3, p=0·0004). " 02/01/2011 - "In the per-protocol analysis, 82 of 415 children in the RTS,S/AS01E group and 125 of 420 in the rabies vaccine group had first or only clinical malaria episode by 12 months, vaccine efficacy 39·2% (95% CI 19·5-54·1, p=0·0005). "

Related Drugs and Biologics

1.	Vaccines
2.	Immunoglobulins (Immunoglobulin)
3.	Antibodies
4.	DNA (Deoxyribonucleic Acid)
5.	Rotavirus Vaccines
6.	DNA Vaccines
7.	Poly I
8.	Poly C (C, Poly)
9.	Pertussis Vaccine
10.	Antigens

Related Therapies and Procedures

1.	Intradermal Injections
2.	Injections
3.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
4.	Intramuscular Injections
5.	Transplantation (Transplant Recipients)